Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Increased activity of the innate immune system has been implicated in the pathogenesis of the dyslipidemia and insulin resistance associated with obesity and type 2 diabetes. In this study, we addressed the potential role of Kupffer cells (liver-specific macrophages, KCs) in these metabolic abnormalities. RESEARCH DESIGN AND METHODS: Rats were depleted of KCs by administration of gadolinium chloride, after which all animals were exposed to a 2-week high-fat or high-sucrose diet. Subsequently, the effects of these interventions on the development of hepatic insulin resistance and steatosis were assessed. In further studies, the effects of M1-polarized KCs on hepatocyte lipid metabolism and insulin sensitivity were addressed. RESULTS: As expected, a high-fat or high-sucrose diet induced steatosis and hepatic insulin resistance. However, these metabolic abnormalities were prevented when liver was depleted of KCs. In vitro, KCs recapitulated the in vivo effects of diet by increasing hepatocyte triglyceride accumulation and fatty acid esterification, and decreasing fatty acid oxidation and insulin responsiveness. To address the mechanisms(s) of KC action, we inhibited a panel of cytokines using neutralizing antibodies. Only neutralizing antibodies against tumor necrosis factor-α (TNFα) attenuated KC-induced alterations in hepatocyte fatty acid oxidation, triglyceride accumulation, and insulin responsiveness. Importantly, KC TNFα levels were increased by diet in vivo and in isolated M1-polarized KCs in vitro. CONCLUSIONS: These data demonstrate a role for liver macrophages in diet-induced alterations in hepatic lipid metabolism and insulin sensitivity, and suggest a role for these cells in the etiology of the metabolic abnormalities of obesity/type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. The effects of KC depletion on the development of liver insulin resistance on a high-fat or high-sucrose diet. Male Wistar rats depleted of KCs or control rats were exposed to a high-fat (A and B) or high-sucrose (C and D) diet for 2 weeks. Subsequently, animals were fasted overnight and then underwent 4 mU · kg−1 · min−1 euglycemic-hyperinsulinemic clamp in the presence of [3-H3]-glucose for the measurement of hepatic insulin sensitivity as described in research design and methods. Hepatic glucose output (A and C) and insulin suppression of hepatic glucose output (B and D) were assessed. Data are presented as means ± SE. Statistical significance is indicated. n = a minimum of four in each group.](https://figures.cochat.ai/paper-figures/1d7aea5fb96a40b789899a32b10fa965/depletion-of-liver-kupffer-cells-prevents-the-development-of-diet-induced-figure-2.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Not surprisingly, depleting hepatic macrophages in mouse models with agents such as clodronate liposomes, or blocking their recruitment pharmacologically, as with the CCR2/CCR5 antagonist Cenicriviroc, attenuate fibrosis and blunt other histologic markers of disease (87–91).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Cited by
Items 201–300 of 520
Calabuig-Navarro, V., Yamauchi, J., Lee, S., Zhang, T., Liu, Y., Sadlek, K., Coudriet, G. M., Piganelli, J. D., Jiang, C., Miller, R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650994 · Cited by 56
Li, J., Li, X., Li, Z., Zhang, L., Liu, Y., Ding, H., & Yin, S. (2017) · Food & Function · doi:10.1039/c7fo00290d · Cited by 56
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
Gwag, T., Mooli, R. G. R., Li, D., Lee, S., Lee, E. Y., & Wang, S. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100193 · Cited by 64
Macrophages as key regulators of liver health and disease
Papachristoforou, E., & Ramachandran, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.006 · Cited by 70
Ruffino, J. S., Davies, N. A., Morris, K., Ludgate, M., Zhang, L., Webb, R., & Thomas, A. W. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3414-y · Cited by 65
Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice
Schmitz, K., Mangels, N., Häußler, A., Ferreirós, N., Fleming, I., & Tegeder, I. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.169 · Cited by 54
Bjørndal, B., Berge, C., Ramsvik, M. S., Svardal, A. M., Bohov, P., Skorve, J., & Berge, R. K. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-143 · Cited by 55
Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis
Liu, Q., Yu, J., Wang, L., Tang, Y., Zhou, Q., Ji, S., Wang, Y., Santos, L., Haeusler, R. A., Que, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.025 · Cited by 51
Madić, V., Petrović, A., Jušković, M., Jugović, D., Djordjević, L., Stojanović, G., & Vasiljević, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113210 · Cited by 48
Gao, D., Jiao, J., Wang, Z., Huang, X., Ni, X., Fang, S., Zhou, Q., Zhu, X., Sun, L., Yang, Z. R., et al. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.04.002 · Cited by 53
Amacher, D. E. (2010) · Toxicology · doi:10.1016/j.tox.2010.10.006 · Cited by 53
Ma, C., Zhang, Q., & Greten, T. F. (2017) · FEBS Journal · doi:10.1111/febs.14209 · Cited by 54
GLP‐1 receptor agonists: effects on the progression of non‐alcoholic fatty liver disease
Liu, J., Wang, G., Jia, Y., & Xu, Y. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2580 · Cited by 48
Pant, R., Kabeer, S. W., Sharma, S., Kumar, V., Patra, D., Pal, D., & Tikoo, K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104779 · Cited by 53
Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
Perfield, J. W., Lee, Y., Shulman, G. I., Samuel, V. T., Jurczak, M. J., Chang, E., Xie, C., Tsichlis, P. N., Obin, M. S., & Greenberg, A. S. (2011) · Diabetes · doi:10.2337/db10-0715 · Cited by 53
Papackova, Z., Palenickova, E., Dankova, H., Zdychova, J., Skop, V., Kazdova, L., & Cahova, M. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-22 · Cited by 49
Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease
Lakhani, H. V., Sharma, D. L., Dodrill, M. W., Nawab, A., Sharma, N., Cottrill, C. L., Shapiro, J. I., & Sodhi, K. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.27953 · Cited by 48
Immune Regulation of Metabolic Homeostasis by Helminths and Their Molecules
van der Zande, H. J. P., Zawistowska‐Deniziak, A., & Guigas, B. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.07.014 · Cited by 52
Kassel, K. M., Owens, A. P., Rockwell, C. E., Sullivan, B. P., Wang, R., Tawfik, O. W., Li, G., Guo, G. L., Mackman, N., & Luyendyk, J. P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.015 · Cited by 52
Computational Approach to Identifying Universal Macrophage Biomarkers
Dang, D., Taheri, S., Das, S., Ghosh, P., Prince, L. S., & Sahoo, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00275 · Cited by 48
Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting
Singanayagam, A., & Triantafyllou, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661182 · Cited by 48
LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
Li, D., Huang, L. T., Kan, R., Meng, X., Wang, S., Zou, H., Guo, Y., Luo, P.-Q., Pan, L., Xiang, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40183-3 · Cited by 50
Zhang, Y., Li, C., Yao, G.-F., Du, L., Liu, Y., Zheng, X., Yan, S., Sun, J., Liu, Y., Liu, M., et al. (2017) · Diabetes · doi:10.2337/db16-1354 · Cited by 48
Yu, J., Zhang, H., Chen, L., Ruan, Y., Chen, Y., & Liu, Q. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.698852 · Cited by 52
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Muynck, K. D., Vanderborght, B., Vlierberghe, H. V., & Devisscher, L. (2021) · Cells · doi:10.3390/cells10112959 · Cited by 53
Immune–metabolic interactions in homeostasis and the progression to NASH
Hoogerland, J. A., Staels, B., & Dombrowicz, D. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.001 · Cited by 48
Gröger, M., Matsuo, K., Arash, E. H., Pereira, A., Guillou, D. L., Pino, C., Telles-Silva, K. A., Maher, J. J., Hsiao, E. C., & Willenbring, H. (2023) · Nature Communications · doi:10.1038/s41467-023-39311-w · Cited by 48
Liu, C., Rajapakse, A. G., Riedo, E., Fellay, B., Bernhard, M. W. S., Montani, J., Yang, Z., & Ming, X. (2016) · Scientific Reports · doi:10.1038/srep20405 · Cited by 48
The role of macrophages in obesity-driven chronic liver disease
Devisscher, L., Verhelst, X., Colle, I., Van Vlierberghe, H., & Geerts, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ru0116-016r · Cited by 44
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
Musso, G., Gambino, R., Cassader, M., Paschetta, E., & Sircana, A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.01.003 · Cited by 47
The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases
Kanmani, P., Kanmani, S., & Kim, H. (2020) · Biomedicines · doi:10.3390/biomedicines8110501 · Cited by 51
Stress kinases in the development of liver steatosis and hepatocellular carcinoma
Cicuéndez, B., Ruiz-Garrido, I., Mora, A., & Sabio, G. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101190 · Cited by 48
Iwaki, M., Kessoku, T., Ozaki, A., Kasai, Y., Kobayashi, T., Nogami, A., Honda, Y., Ogawa, Y., Imajo, K., Yoneda, M., et al. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15487 · Cited by 50
Jeelani, I., Moon, J.-S., da Cunha, F. F., Nasamran, C. A., Jeon, S., Zhang, X., Bandyopadhyay, G. K., Dobaczewska, K., Mikulski, Z., Hosseini, M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0284 · Cited by 52
Qi, L., Gröger, M., Sharma, A., Goswami, I., Chen, E., Zhong, F., Ram, A., Healy, K. E., Hsiao, E. C., Willenbring, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52258-w · Cited by 54
Kassel, K. M., Sullivan, B. P., Cui, W., Copple, B. L., & Luyendyk, J. P. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.011 · Cited by 47
Subramanian, S., Pallati, P. K., Rai, V., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2017) · Obesity · doi:10.1002/oby.21714 · Cited by 47
Chatzigeorgiou, A., & Chavakis, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_8 · Cited by 48
Programmed cell death and lipid metabolism of macrophages in NAFLD
Xiao, Z., Liu, M., Yang, F., Liu, G., Liu, J., Zhao, W., Ma, S., & Duan, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1118449 · Cited by 42
Paiva, A. A., Raposo, H. F., Wanschel, A. C. B. A., Nardelli, T. R., & Oliveira, H. C. F. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1838679 · Cited by 44
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b
Patel, S. J., Liu, N., Piaker, S., Gulko, A., Andrade, M. L., Heyward, F. D., Sermersheim, T. J., Edinger, N., Srinivasan, H., Emont, M. P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abh3831 · Cited by 42
Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance
Xu, E., Charbonneau, A., Rolland, Y., Bellmann, K., Pao, L. I., Siminovitch, K. A., Neel, B. G., Beauchemin, N., & Marette, A. (2012) · Diabetes · doi:10.2337/db11-1502 · Cited by 45
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Otunola, G. A., & Afolayan, A. J. (2015) · Frontiers in Life Science · doi:10.1080/21553769.2015.1053628 · Cited by 57
Xu, Z., Zhang, X., Lau, J. K. C., & Yu, J. Q. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.16 · Cited by 44
Wang, P., Ni, M., Tian, Y., Wang, H., Qiu, J., You, W., Song, W., Shi, Y., Zhou, J., Cheng, F., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102427 · Cited by 42
Chen, Z., Shen, H., Sun, C., Yin, L., Tang, F., Zheng, P., Liu, Y., Brink, R. A., & Rui, L. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00470.2014 · Cited by 43
Chen, H., Yen, C., Kuo, L.-L., Lo, C., Huang, C., Chen, C.-C., & Lii, C. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114941 · Cited by 42
Nobiletin mitigates NAFLD via lipophagy and inflammation
Yang, X., Deng, Y., Tu, Y., Feng, D., & Liao, W. (2022) · Food & Function · doi:10.1039/d2fo01682f · Cited by 39
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
Zhou, E., Ge, X., Nakashima, H., Li, R., van der Zande, H. J. P., Liu, C., Li, Z., Müller, C., Bracher, F., Mohammed, Y., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216845 · Cited by 41
Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation
Guri, A. J., & Bassaganya-Riera, J. (2010) · Obesity · doi:10.1038/oby.2010.230 · Cited by 43
Yamada, K., Mizukoshi, E., Seike, T., Horii, R., Kitahara, M., Sunagozaka, H., Arai, K., Yamashita, T., Honda, M., & Kaneko, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191026 · Cited by 38
González‐Muniesa, P., Marrades, M. P., Martínez, J. A., & Moreno-Aliaga, M. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917238 · Cited by 40
Yang, L., Feng, T., Zhao, J., Jiang, P., Xu, D., Zhou, M., Dai, M., Wu, J., Sun, F., Yang, X., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.810143 · Cited by 39
Fang, X., Zou, S., Zhao, Y., Cui, R., Zhang, W., Hu, J., & Dai, J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0877-4 · Cited by 38
Role of spleen-derived IL-10 in prevention of systemic low-grade inflammation by obesity [Review]
Gotoh, K., Fujiwara, K., Anai, M., Okamoto, M., Masaki, T., Kakuma, T., & Shibata, H. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0060 · Cited by 41
Nagashima, T., Kamata, Y., Iwamoto, M., Okazaki, H., Fukushima, N., & Minota, S. (2019) · Rheumatology International · doi:10.1007/s00296-019-04255-2 · Cited by 36
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 43
The immune response as a therapeutic target in non-alcoholic fatty liver disease
Ortiz‐López, N., Fuenzalida, C., Dufeu, M. S., Pinto-León, A., Escobar, A. F., Poníachik, J., Roblero, J. P., Valenzuela-Pérez, L., & Beltrán, C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954869 · Cited by 40
The Macrophage A2b Adenosine Receptor Regulates Tissue Insulin Sensitivity
Johnston‐Cox, H., Eisenstein, A. S., Koupenova, M., Carroll, S. H., & Ravid, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098775 · Cited by 36
Bisphenol A promotes hepatic lipid deposition involving Kupffer cells M1 polarization in male mice
Lv, Q., Gao, R., Peng, C., Yi, J., Liu, L., Yang, S., Li, D., Hu, J., Luo, T., Mei, M., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0028 · Cited by 40
Probiotics, Prebiotics, Energy Balance, and Obesity
Molinaro, F., Paschetta, E., Cassader, M., Gambino, R., & Musso, G. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.009 · Cited by 48
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice
Zou, Z., Liu, X., Yu, J., Ban, T., Zhang, Z., Wang, P., Huang, R., Zheng, F., Chang, Y., Peng, W., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.029 · Cited by 41
Boccatonda, A., Cane, L. D., Marola, L., D’Ardes, D., Lessiani, G., Gregorio, N. D., Ferri, C., Cipollone, F., Serra, C., Santilli, F., et al. (2024) · Life · doi:10.3390/life14040473 · Cited by 40
Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver
Davidson, M. D., Lehrer, M., & Khetani, S. R. (2015) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2014.0512 · Cited by 34
Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
Chen, W., Zhang, J., Fan, H., & Zhu, J. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818815184 · Cited by 37
ANT2 drives proinflammatory macrophage activation in obesity
Moon, J.-S., da Cunha, F. F., Huh, J. Y., Andreyev, A. Y., Lee, J., Mahata, S. K., Reis, F. C. G., Nasamran, C. A., & Lee, Y. S. (2021) · JCI Insight · doi:10.1172/jci.insight.147033 · Cited by 39
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 37
Innate immunity and early liver inflammation
Zhou, J. Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175147 · Cited by 40
Gut microbiota in MAFLD: therapeutic and diagnostic implications
Alghamdi, W., Mosli, M. H., & Alqahtani, S. A. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241242937 · Cited by 34
Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype
McAlpine, C. S., Huang, A., Emdin, A. L., Banko, N. S., Beriault, D. R., Shi, Y., & Werstuck, G. H. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305438 · Cited by 35
Paraiso, I. L., Tran, T. Q., Magaña, A. A., Kundu, P., Choi, J., Maier, C. S., Bobe, G., Raber, J., Kioussi, C., & Stevens, J. F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643857 · Cited by 35
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
Wen, Y., Ma, L., & Ju, C. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100020 · Cited by 31
Kupffer cells facilitate the acute effects of leptin on hepatic lipid metabolism
Metlakunta, A. S., Huang, W., Stefanović-Račić, M., Dedousis, N. L., SIPULA, I. J., & O'Doherty, R. M. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00250.2016 · Cited by 32
Self-citationNuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells
Li, Z., Kruijt, J. K., der Sluis, R. J. V., Berkel, T. J. C. V., & Hoekstra, M. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00151.2012 · Cited by 31
High Glucose‐Aggravated Hepatic Insulin Resistance: Role of the NLRP3 Inflammasome in Kupffer Cells
Zheng, T., Wang, Q., Dong, Y., Ma, W., Zhang, Y., Zhao, Y., Bian, F., & Chen, L. (2020) · Obesity · doi:10.1002/oby.22821 · Cited by 31
GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis
Chen, Y., Xu, Y.-N., Ye, C.-Y., Feng, W., Zhou, Q., Yang, D., & Wang, M. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00836-9 · Cited by 34
Krishna, K. B., Stefanović-Račić, M., Dedousis, N. L., SIPULA, I. J., & O'Doherty, R. M. (2016) · Physiological Reports · doi:10.14814/phy2.12708 · Cited by 36
Self-citationThe diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 34
VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan‐Stevenson, V., Ogimoto, K., Kanter, J. E., Bornfeldt, K., Daum, G., Clowes, A. W., et al. (2013) · Diabetes · doi:10.2337/db12-0325 · Cited by 32
Fructose and Cardiometabolic Disorders: The Controversy Will, and Must, Continue
Wiernsperger, N. F., Géloën, A., & Rapin, J. R. (2010) · Clinics · doi:10.1590/s1807-59322010000700013 · Cited by 34
Biagioli, M., Marchianò, S., di Giorgio, C., Roselli, R., Bordoni, M., Bellini, R., Fiorillo, B., Sepe, V., Catalanotti, B., Cassiano, C., et al. (2023) · Hepatology · doi:10.1002/hep.32787 · Cited by 28
Li, Y., Sun, J.-P., Wang, J., Lu, W., Xie, L., Lv, J., Li, H., & Yang, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.045 · Cited by 28
Current, emerging, and potential therapies for non-alcoholic steatohepatitis
Yang, Z. L., & Wang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152042 · Cited by 32
Liver response of rabbits to Eimeria coecicola infections
Al‐Quraishy, S., Metwaly, M. S., Dkhil, M. A., Abdel‐Baki, A. S., & Wunderlich, F. T. (2011) · Parasitology Research · doi:10.1007/s00436-011-2574-2 · Cited by 28
Alcoholic hepatitis: The pivotal role of Kupffer cells
Suraweera, D. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.90 · Cited by 31
Zhong, L., Huang, L., Xue, Q., Liu, C., Xu, K., Shen, W., & Deng, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28456 · Cited by 26
Metabolic immunomodulation of macrophage functional plasticity in nonhealing wounds
Anders, C. B., Lawton, T., & Ammons, M. C. B. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000550 · Cited by 27
Choi, D., Ban, J.-O., Kim, S.-C., & Hong, J. T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1253-3 · Cited by 27
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
Liu, J., Sun, X., Zhang, F.-L., Jin, H., Yan, X., Huang, S., Guo, Z., & Yang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596811 · Cited by 31
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis
Huang, H., Fan, S., Zhou, X., Liu, Y., Xiao, L., Liao, L., Huang, J. L., Shi, C., Liang, Y., Fu, R., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00725-1 · Cited by 31
Li, W., Deng, M., Gong, J., Hou, Y., & Zhao, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065536 · Cited by 28
Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice
van Diepen, J. A., Wong, M. C., Guigas, B., Bos, J. E., Stienstra, R., Hodson, L., Shoelson, S. E., Berbée, J. F. P., Rensen, P. C. N., Romijn, J. A., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m010405 · Cited by 29
Wu, R., Nakatsu, G., Zhang, X., & Yu, J. Q. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1125883 · Cited by 29
Liu, C., Morin, J., Dokmanovich, M., Bluette, C. T., Goldstein, R., Manickam, B., & Bagi, C. M. (2019) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2019.02.003 · Cited by 28
Cheong, H., Lee, S. S., Lee, J. S., Kim, J., Kim, S. W., & Lee, W. J. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24674 · Cited by 27
AlAsfoor, S., Rohm, T. V., Bosch, A. J. T., Dervos, T., Calabrese, D., Matter, M. S., Weber, A., & Cavelti‐Weder, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-32853-w · Cited by 29
Li, X., Ji, P., Ni, X., Chen, Y., Li, S., Lian, M., Guo, C., & Hua, J. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1365 · Cited by 27
Song, J., Gao, J., Du, ., & Mao, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.03.044 · Cited by 24
Xu, D., Zhao, W., Feng, Y., Wen, X., Liu, H., & Ping, J. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154368 · Cited by 26
Metadata
- Authors
- Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M.
- Affiliations
- University of Pittsburgh (US)
- Department of Medicine, Division of Endocrinology and Metabolism, University of Pittsburgh, Pittsburgh, Pennsylvania;
- Corresponding author
- O'Doherty, Robert M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-11-23
- Volume
- 59
- Issue
- 2
- Pages
- 347-357
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2809951
- OpenAlex
- W2138774651
- Cited by
- 520
- References
- 53
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 24 · 2023: 36 · 2022: 35 · 2021: 38 · 2020: 49 · 2019: 29 · 2018: 33 · 2017: 35 · 2016: 30 · 2015: 33 · 2014: 33 · 2013: 32 · 2012: 30
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072162, R01DK065149, R01DK058855)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- Kupffer cells, hepatic macrophages, hepatic steatosis, insulin resistance, diet-induced obesity, type 2 diabetes, TNF-α, M1 macrophage polarization, hepatocyte lipid metabolism, fatty acid oxidation, triglyceride accumulation, innate immunity, high-fat diet, high-sucrose diet
- MeSH terms
- CD68 Molecule, Adipose Tissue, Animals, Antigens, Differentiation, Energy Intake, Dietary Fats, Fatty Liver, Gadolinium, Immunohistochemistry, Insulin Resistance, Kupffer Cells, Liver, Male, Membrane Glycoproteins, Sucrose, Antigens, Differentiation, Myelomonocytic, Glucose Clamp Technique, Antigens, CD, Rats, Wistar, Hepatocytes, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.